Skip to main content
Premium Trial:

Request an Annual Quote

Integrated DNA Technologies Obtains Right to Sell ddRNAi Oligos from Promega

NEW YORK, June 10 (GenomeWeb News) - Integrated DNA Technologies has licensed DNA-directed RNA interference technology from Promega, the company said yesterday.

 

Under the non-exclusive agreement, IDT can make and sell oligos for use in ddRNAi. The company, based in Coralville, Iowa, is the first oligonucleotide manufacturer in the US to obtain a ddRNAi license from Promega.

 

Promega, in turn, holds an exclusive license from Benitec that allows it to sell custom ddRNAi-related oligos and related services. The technology is protected in the United States by US patent No. 6,573,099.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.